Source: https://www.medipolis.be/nl/artsen/specialisme/oogheelkunde/prof-dr-de-keyser-myrjam
Timestamp: 2019-04-25 18:09:56+00:00

Document:
Myrjam BJ De Keyser, MD, is vaste medewerker te Medipolis.
Sinds 1991 is zij werkzaam in het Antwerpse als retina- en glaucoomspecialiste; sinds 2016 in Medipolis.
Guest-professor aan de Universiteit van Antwerpen, november 2016.
De Keyser M, Vissenberg I, Neetens A. Use of Visual Evoked Potentials to determine visual acuity. Neuro-Ophthalmology Symposium at the Congress of the European Society of Ophthalmology, Brussels, Nov 20, 1991.
De Keyser M, Van Den Ende P, Neetens A. Recent acquisitions in evaluation of sensorial visual functions. Neuro-Ophthalmology Symposium at the Antwerp University Hospital, Antwerp, June 1991.
De Keyser M. Glaucoma, to see or not to see. General Practitioners Symposium, ZNA Jan Palfijn, Antwerp, Belgium, Febr 4, 2012.
De Keyser M, De Belder M, De Groot V. Anti-inflammatory drops after selective laser trabeculoplasty. Congres of European Society of Ophthalmology, 2015, Vienna, Austria, June 7, 2015.
De Keyser M, De Belder M, Mannaerts M, De Groot V. Effect of prior cataract surgery on short term outcome of selective laser trabeculoplasty in pseudophakic and phakic patients. Ophthalmologica Belgica, Brussels Square, Brussels, Jan 11, 2016.
De Keyser M, De Belder M, De Groot V. Selective laser trabeculoplasty in pseudophakic and phakic eyes. 12th European Congress of Glaucoma, Prague, June 2016.
De Keyser M, De Belder M, De Groot V. Selective laser trabeculoplasty in normal tension glaucoma. Ophtalmologica Belgica, Brussel, Nov. 23, 2016.
De Keyser M, De BZlder M, De Groot V. Treatement-related quality of life in glaucoma patients: comparison of selective laser trabeculoplasty and medication. Ophtalmologica Belgica, Brussels, Nov. 23, 2016.
De Keyser M, De Belder M, De Groot V. Treatment related quality of live after selective laser trabeculoplasty. World Glaucoma Congres, Helsinki, June 29. 2017.
De Keyser M, De Belder M, De Groot V. Selective laser trabeculoplasty as replacement therapy in glaucoma. World Glaucoma Congres, Helsinki, June 29. 2017.
In 2013 begon zij aan een doctoraatsstudie rond selectieve laser trabeculoplastie, een veelbelovende glaucoombehandeling. In 2017 werd deze studie afgerond met de verdediging van een doctoraatsthesis.
M. De Keyser, I. Vissenberg, A. Neetens. Are visually evoked potentials (VEP) useful for determination of visual acuity? A clinical trial. Neuro-ophthalmology, 1990, Vol. 10, No. 3, pp. 153-163.
De Belder F, Van Goethem J, Bosmans J, Venstermans C, van den Hauwe L, De Keyser M, Parizel P M. Spectroscopy for dummies. Syllabus Erasmus Course EMRI CNSII (ISBN 978 90 810 9303 3), 2009, 273-295.
De Keyser M. Power is not energy. Journal of Glaucoma Journal of Glaucoma, May 5, 2016.
De Keyser M, De Belder M, De Groot V. Prospective randomized trial on treatment-related quality of life in glaucoma patients: comparison between selective laser trabeculoplasty and medication. In submission.
De Keyser M, De Belder M, De Groot V. Randomized prospective study of the use of anti-inflammatory drops after selective laser trabeculoplasty. Accepted for publication by Journal of Glaucoma.
De Keyser M, De Belder M, De Groot V. Selective laser trabeculoplasty in pseudophakic and phakic eyes. Accepted for publication by International Journal of Ophthalmology.
De Keyser M, De Belder M, De Groot V. Quality of life in glaucoma patients after selective laser trabeculoplasty. International Jorunal of Ophtalmology, 2017;20;5:742-748.
De Keyser M, De Belder J, De Groot V. Effect of selective laser trabeculoplasty in glaucoma patients with high or low central corneal thickness. Insights in ophtalmology, 2017; 1:1:1-7.
De Keyser M, De Belder J, De Groot V. Selective laser trabeculoplasty as replacement therapy in medically glaucoma patients. Acta Ophtalmologica, 2017; 21 June. DOI:10.1111/aos.13509.

References: V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V.